Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic – Correspondence
Ranjan K. Mohapatra, Venkataramana Kandi, Ashish K. Sarangi, et al.
International Journal of Surgery (2022) Vol. 103, pp. 106698-106698
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Update on the omicron sub‐variants BA.4 and BA.5
Trina Ekawati Tallei, Saad Alhumaid, Zainab AlMusa, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 75
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
Linear versus cubic regression models for analyzing generalized reverse degree based topological indices of certain latest corona treatment drug molecules
Micheal Arockiaraj, A. Berin Greeni, AR. Abul Kalaam
International Journal of Quantum Chemistry (2023) Vol. 123, Iss. 16
Closed Access | Times Cited: 45
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Mary‐Ann Davies, Erna Morden, Petro Rousseau, et al.
International Journal of Infectious Diseases (2022) Vol. 127, pp. 63-68
Open Access | Times Cited: 57
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 51
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study
Chenyuan Qin, Wenxin Yan, Min Du, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 47
Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
GeroScience (2022) Vol. 44, Iss. 6, pp. 2895-2911
Open Access | Times Cited: 37
Omicron subvariant BA.5 efficiently infects lung cells
Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111998-111998
Open Access | Times Cited: 22
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 21
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants
Dima Hattab, Mumen F. A. Amer, Zina M. Al‐Alami, et al.
Infection (2024) Vol. 52, Iss. 3, pp. 767-786
Open Access | Times Cited: 13
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Zoonosis and zooanthroponosis of emerging respiratory viruses
Ahmed Magdy Khalil, Luis Martínez‐Sobrido, Ahmed Mostafa
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 8
The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China
Chenyuan Qin, Wenxin Yan, Liyuan Tao, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1112-1112
Open Access | Times Cited: 35
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 1, pp. 103-122
Open Access | Times Cited: 35
The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
Md. Rabiul Islam, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 34
Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
Juan C. Almagro, Gabriela Mellado‐Sánchez, Martha Pedraza‐Escalona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9763-9763
Open Access | Times Cited: 29
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
SubbaRao V. Tulimilli, Siva Dallavalasa, Chaithanya G. Basavaraju, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1751-1751
Open Access | Times Cited: 28
Emergence of mRNA vaccines in the management of cancer
Mohamad Irfan Mohamad Razif, Nabilah Nizar, Nur Hannah Zainal Abidin, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 629-642
Open Access | Times Cited: 17
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Impact of African-Specific ACE2 Polymorphisms on Omicron BA.4/5 RBD Binding and Allosteric Communication Within the ACE2–RBD Protein Complex
Victor Barozi, Özlem Taştan Bishop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1367-1367
Open Access
The rapid emergence of multiple sublineages of Omicron (B.1.1.529) variant: Dynamic profiling via molecular phylogenetics and mutational landscape studies
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1234-1258
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top